Alimera makes fourth bid for eye treatment approval from FDA
March 27, 2014 at 07:48 AM EDT
March 27 (Reuters) - Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients.